OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of Aberrations in the Immune-Inflammatory Response System (IRS) and the Compensatory Immune-Regulatory Reflex System (CIRS) in Different Phenotypes of Schizophrenia: the IRS-CIRS Theory of Schizophrenia
Chutima Roomruangwong, Cristiano Noto, Buranee Kanchanatawan, et al.
Molecular Neurobiology (2019) Vol. 57, Iss. 2, pp. 778-797
Closed Access | Times Cited: 136

Showing 1-25 of 136 citing articles:

Evidence-based umbrella review of 162 peripheral biomarkers for major mental disorders
André F. Carvalho, Marco Solmi, Marcos Sanches, et al.
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 169

Immune System Abnormalities in Schizophrenia: An Integrative View and Translational Perspectives
Evgeny A. Ermakov, Mark M. Melamud, Valentina N. Buneva, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 92

Neuroinflammation in Schizophrenia: The Key Role of the WNT/β-Catenin Pathway
Alexandre Vallée
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2810-2810
Open Access | Times Cited: 84

Inflammation and nitro-oxidative stress in current suicidal attempts and current suicidal ideation: a systematic review and meta-analysis
Asara Vasupanrajit, Ketsupar Jirakran, Chavit Tunvirachaisakul, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 3, pp. 1350-1361
Open Access | Times Cited: 82

The tryptophan catabolite or kynurenine pathway in schizophrenia: meta-analysis reveals dissociations between central, serum, and plasma compartments
Abbas F. Almulla, Asara Vasupanrajit, Chavit Tunvirachaisakul, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 9, pp. 3679-3691
Open Access | Times Cited: 63

Shedding light on biological sex differences and microbiota–gut–brain axis: a comprehensive review of its roles in neuropsychiatric disorders
Parnian Shobeiri, Amirali Kalantari, António Teixeira, et al.
Biology of Sex Differences (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 59

Biological hypotheses, risk factors, and biomarkers of schizophrenia
Zdeněk Fišar
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 120, pp. 110626-110626
Closed Access | Times Cited: 57

Linking Inflammation, Aberrant Glutamate-Dopamine Interaction, and Post-synaptic Changes: Translational Relevance for Schizophrenia and Antipsychotic Treatment: a Systematic Review
Andrea de Bartolomeis, Annarita Barone, Licia Vellucci, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 10, pp. 6460-6501
Open Access | Times Cited: 54

Immunophenotypes in psychosis: is it a premature inflamm-aging disorder?
Song Chen, Yunlong Tan, Li Tian
Molecular Psychiatry (2024) Vol. 29, Iss. 9, pp. 2834-2848
Open Access | Times Cited: 8

Lowered Antioxidant Defenses and Increased Oxidative Toxicity Are Hallmarks of Deficit Schizophrenia: a Nomothetic Network Psychiatry Approach
Michaël Maes, Sunee Sirivichayakul, Andressa Keiko Matsumoto, et al.
Molecular Neurobiology (2020) Vol. 57, Iss. 11, pp. 4578-4597
Closed Access | Times Cited: 58

Upregulation of the Intestinal Paracellular Pathway with Breakdown of Tight and Adherens Junctions in Deficit Schizophrenia
Michaël Maes, Sunee Sirivichayakul, Buranee Kanchanatawan, et al.
Molecular Neurobiology (2019) Vol. 56, Iss. 10, pp. 7056-7073
Closed Access | Times Cited: 55

Suicide attempts are associated with activated immune-inflammatory, nitro-oxidative, and neurotoxic pathways: A systematic review and meta-analysis
Asara Vasupanrajit, Ketsupar Jirakran, Chavit Tunvirachaisakul, et al.
Journal of Affective Disorders (2021) Vol. 295, pp. 80-92
Open Access | Times Cited: 54

High Mobility Group Protein 1 and Dickkopf-Related Protein 1 in Schizophrenia and Treatment-Resistant Schizophrenia: Associations With Interleukin-6, Symptom Domains, and Neurocognitive Impairments
Arafat Hussein Al-Dujaili, Rana Fadhil Mousa, Hussein Kadhem Al‐Hakeim, et al.
Schizophrenia Bulletin (2020) Vol. 47, Iss. 2, pp. 530-541
Open Access | Times Cited: 53

Increased Levels of Plasma Tumor Necrosis Factor-α Mediate Schizophrenia Symptom Dimensions and Neurocognitive Impairments and Are Inversely Associated with Natural IgM Directed to Malondialdehyde and Paraoxonase 1 Activity
Michaël Maes, Sunee Sirivichayakul, Andressa Keiko Matsumoto, et al.
Molecular Neurobiology (2020) Vol. 57, Iss. 5, pp. 2333-2345
Closed Access | Times Cited: 50

Serum interleukin-6 in schizophrenia: A system review and meta-analysis
Xin Zhou, Bo Tian, Hai-Bin Han
Cytokine (2021) Vol. 141, pp. 155441-155441
Closed Access | Times Cited: 50

The role of high-density lipoprotein cholesterol, apolipoprotein A and paraoxonase-1 in the pathophysiology of neuroprogressive disorders
Gerwyn Morris, Basant K. Puri, Chiara C. Bortolasci, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 125, pp. 244-263
Closed Access | Times Cited: 50

Interactions Among Brain-Derived Neurotrophic Factor and Neuroimmune Pathways Are Key Components of the Major Psychiatric Disorders
Nikolay Mehterov, D. Minchev, Maria Gevezova, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 8, pp. 4926-4952
Closed Access | Times Cited: 31

Kynurenine pathway abnormalities are state-specific but not diagnosis-specific in schizophrenia and bipolar disorder
Katrien Skorobogatov, Valérie Autier, Marianne Foiselle, et al.
Brain Behavior & Immunity - Health (2023) Vol. 27, pp. 100584-100584
Open Access | Times Cited: 21

Redox and Immune Signaling in Schizophrenia: New Therapeutic Potential
Daniella Dwir, Inès Khadimallah, Lijing Xin, et al.
The International Journal of Neuropsychopharmacology (2023) Vol. 26, Iss. 5, pp. 309-321
Open Access | Times Cited: 17

HERV-W upregulation expression in bipolar disorder and schizophrenia: unraveling potential links to systemic immune/inflammation status
Sara Coelho Rangel, Michelly Damasceno da Silva, Décio Gilberto Natrielli Filho, et al.
Retrovirology (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 6

Mitochondria and immunity in chronic fatigue syndrome
George Anderson, Michaël Maes
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 103, pp. 109976-109976
Closed Access | Times Cited: 48

In schizophrenia, immune-inflammatory pathways are strongly associated with depressive and anxiety symptoms, which are part of a latent trait which comprises neurocognitive impairments and schizophrenia symptoms.
Abbas F. Almulla, Khalid F. Al-Rawi, Michaël Maes, et al.
Journal of Affective Disorders (2021) Vol. 287, pp. 316-326
Closed Access | Times Cited: 35

Delirium due to hip fracture is associated with activated immune-inflammatory pathways and a reduction in negative immunoregulatory mechanisms
Paul Thisayakorn, Yanin Thipakorn, Saran Tantavisut, et al.
BMC Psychiatry (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 27

Page 1 - Next Page

Scroll to top